Fen Lai Tan
Directeur/Membre du Conseil chez Capio Biosciences, Inc.
Profil
Fen Lai Tan is currently a Director at Capio Biosciences, Inc. Prior to this, he worked as a Director, Chief Medical Officer & Senior VP at Betta Pharmaceuticals Co., Ltd.
from 2013 to 2018.
Dr. Tan holds a doctorate degree from The University of Arkansas.
Postes actifs de Fen Lai Tan
| Sociétés | Poste | Début |
|---|---|---|
Capio Biosciences, Inc.
 Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Directeur/Membre du Conseil | - |
Anciens postes connus de Fen Lai Tan
| Sociétés | Poste | Fin |
|---|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Directeur Technique/Scientifique/R&D | 26/03/2018 |
Formation de Fen Lai Tan
| The University of Arkansas | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Capio Biosciences, Inc.
Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Health Technology |
